17.03.2024, 1565 Zeichen

Verbund: Utility group VERBUND increased its results of operations and significantly improved all relevant KPIs. EBITDA climbed by 42.1% year-on-year to €4,490.5m. The reported Group result rose by 32.0% to €2,266.1m and the Group result after adjustment for non-recurring effects was up 49.1% (non-recurring effects in 2023: €–349.7m; 2022: €–37.9m). At 0.98, the hydro coefficient for the run-of-river power plants was 2 percentage points below the long-term average, but 12 percentage points above the comparative prior-year figure. Generation from the annual storage power plants was up 9.6% year-on-year in 2023. Generation from hydropower thus increased by 3,755 GWh to 30,509 GWh. The sharp rise in wholesale electricity prices on the futures markets that were relevant for the reporting period also gave earnings a large boost. By contrast, prices on the spot markets declined in 2023.
Verbund: weekly performance: -1.90%

Frequentis: Frequentis, a global supplier of communication and information systems for control centres with safety-critical tasks, to deploy aviation message handling solution across India in one of the world’s largest ever setups. With over 60 sites across remote locations and approximately 200 user terminals, this project will provide increased performance and unmatched resilience, as well as being one of the largest deployed installations for a single customer worldwide, marking a global AMHS milestone.
Frequentis: weekly performance: 4.03%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (14/03/2024)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1198: ATX schwächer, guter Tag für Semperit, 2. Versuch vom Sommerloch und eine klare Präferenz bei Addiko Bank

Bildnachweis

Aktien auf dem Radar:Porr, Kapsch TrafficCom, Flughafen Wien, EuroTeleSites AG, RHI Magnesita, Austriacard Holdings AG, OMV, Telekom Austria, voestalpine, Verbund, SBO, Lenzing, Strabag, FACC, Bawag, Andritz, Addiko Bank, Frequentis, RBI, Semperit, BKS Bank Stamm, Marinomed Biotech, Amag, CPI Europe AG, Österreichische Post, UBM, IBM, Goldman Sachs, Commerzbank, Fresenius Medical Care, Mercedes-Benz Group.

---